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Both E12 and E47 Allow Commitment
to the B Cell Lineage
Gretchen Bain,* Els C. Robanus Maandag,† and Grosschedl, 1995). Pax-5 belongs to the paired
Hein P. J. te Riele,† Ann J. Feeney,‡ Ann Sheehy,‖ class of homeodomain proteins and is expressed in all
Mark Schlissel,‖ Susan A. Shinton,§ Richard R. Hardy,§ B lineage cells with the exception of the terminally differ-
and Cornelis Murre* entiated plasma cells (Barberis et al., 1990). B lympho-
*Department of Biology cytes in Pax-5 null mutant mice are blocked prior to a
University of California, San Diego stage at which VDJH joints are formed (Urbanek et al.,
La Jolla, California 92093 1994).
†Department of Molecular Genetics The E2A gene codes for two basic–helix-loop-helix
The Netherlands Cancer Institute (HLH) proteins, designated E12 and E47, which arise
Plesmanlaan 121 through differential splicing to the exon that codes for
1066 CX Amsterdam the HLH domain (Murre at al., 1989a). Within the HLH
The Netherlands domain they differ from each other by 20% (Murre et
‡Department of Immunology al., 1989a). E12 and E47 have distinct biochemical prop-
The Scripps Research Institute erties: E47 homodimers bind with high affinity to DNA,
10666 North Torrey Pines Road whereas an inhibitory domain prevents E12 homodimers
La Jolla, California 92037 from high affinity DNAbinding (Sun and Baltimore, 1991).
§ Institute for Cancer Research The E2A polypeptides have been shown to bind to
Fox Chase Cancer Center E-box sites present in a wide variety of tissue-specific
Philadelphia, Pennsylvania 19111 enhancers, including the insulin, muscle creatine kinase,‖Departments of Medicine CD4, and immunoglobulin intronic and 39 enhancers
and Molecular Biology and Genetics (Murre et al., 1991; Lassar et al., 1991; Bain et al., 1993;
The Johns Hopkins University School of Medicine Sawada and Littman, 1993; Jacobs et al., 1994; Pongu-
Baltimore, Maryland 21205 bala and Atchison, 1991; Shen and Kadesch, 1995). In
non-B cells, E2A polypeptides bind as heterodimers with
tissue-specific HLH proteins to activate tissue-specific
Summary gene expression. In pre-B and mature B cells, homodi-
mers of E2A bind to E2-box sites in the immunoglobulin
The E2A gene products, E12 and E47, are required for gene enhancers (Murre et al., 1991; Bain et al., 1993;
proper B cell development. Mice lacking the E2A gene Benezra, 1994; Shen and Kadesch, 1995).
products generate only a very small number of B2201 An important role for E2A in early B lineage develop-
cells, which lack immunoglobulin DJH rearrangements. ment has been suggested on the basis of two findings.
We have now generated mice expressing either E12
First, E2A binding activity is induced after initiation of
or E47. B cell development in mice expressing E12 but
B lymphopoiesis, but prior to immunoglobulin heavylacking E47 is perturbed at the pro-B cell stage, and
chain gene expression (Xin et al., 1994). Second, overex-these mice lack IgM1B2201 B cells in both bone mar-
pression of E47 in a pre-T cell line induces germlinerow and spleen. IgM1B2201 B cells can be detected,
immunoglobulin heavy chain gene expression, DJH re-albeit at significantly reduced levels, in the bone mar-
arrangement, and increased levels of RAG gene expres-row and spleen of mice lacking E12. Ectopic expres-
sion (Schlissel et al., 1991a). That E2A gene productssion of both E12 and E47 in a null mutant background
play a critical role in B lymphocyte development wasshows that E12 and E47 act in concert to promote B
demonstrated in E2A null mutant mice and transgeniclineage development. Taken together, the data indi-
mice expressing Id1, a negative regulator of E2A (Baincate that both E12 and E47 allow commitment to the
et al., 1994; Sun, 1994; Zhuang et al., 1994). E2A2/2 miceB cell lineage and act synergistically to promote B
lack pre-B and mature B cells and generate only a verylymphocyte maturation.
small number of CD431B2201 cells (Zhuang et al., 1994;
Bain et al., 1994). Fetal liver and bone marrow from
E2A2/2 mice show no detectable IgH rearrangements,Introduction
no RAG expression, and dramatically reduced levels of
B lineage–specific transcripts (Bain et al., 1994; ZhuangEarly B lymphocyte development, like all differentiation
et al., 1994). These data demonstrate that the E2A pro-processes, is controlled by a diverse set of transcrip-
teins are essential for proper B lineage development.tional regulators.The roles of several transcriptional reg-
To determine whether E12 and E47 have distinct rolesulators in B lymphocyte development have been as-
in lymphocyte development, we generated mice ex-sessed recently using null mutant mice. Among these
pressing either E12 or E47. Both E12 and E47 allowfactors are EBF, Pax-5, and the E2A gene products. EBF
commitment to the B lineage. Furthermore, we showis required for proper mb-1 expression and is expressed
that E12 enhances the ability of E47 to promote B cellat all antigen-independent stages of B cell development
differentiation. These data suggest that E12 and E47 are(Hagman et al., 1993). B lymphocytes in EBF null mutant
both required for proper B lineage development, actingmice are blocked prior to the stage at which immuno-
globulin H (IgH) gene rearrangements are initiated (Lin in concert to promote B lymphocyte development.
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Results
Generation of Mice Expressing E12
but Lacking E47
To determine the individual roles of the E2A proteins
in lymphocyte development, we generated null mutant
mice lacking either E12 or E47. To generate E47 null
mutant mice, we introduced the neomycin resistance
gene into the E47-specific HLH exon (Figure 1A). The
E47-neo construct was electroporated into embryonic
stem (ES) cells, and G418-resistant clones were screened
for homologous recombination by Southern blotting us-
ing radiolabeled probe A (Figures 1A and 1B). Of the
100 clones analyzed, approximately 10% had under-
gone homologous recombination. Two ES cell clones
containing the homologous recombination event were
used to generate chimeric mice (Figure 1B). The chime-
ric mice were bred into FVB mice to generate mice het-
erozygous for the E47 recombination event. The hetero-
zygous mice were crossed and the litters were screened
for homozygous mutants. Homozygous mice were
somewhat smaller than their littermates, but did not
show any gross abnormalities. Whereas E2A-deficient
mice have a high degree of postnatal lethality (95%–
98%), most E47 null mutants survive to maturity (.80%).
We performed Western blotting on thymus nuclear
extract to determine E2A protein levels in the E472/2
mice. As expected, E47, which is easily detectable in
nuclear extracts from wild-type mice, is absent in ex-
tracts obtained from E472/2 mice (data not shown).How-
ever, E12 was expressed at levels that were at least
5-fold lower in the E472/2 mice as compared with their
wild-type littermates (data not shown). While insertion
of the neomycin resistance gene into the E47-specific
exon resulted in significantly reduced levels of E12, the
protein present in the E47 null mutants is clearly func-
tional, since E472/2 mice have a significantly lower rate
of postnatal lethality as compared with the E2A2/2 mice.
While the presence of E12 rescues postnatal lethality,
its low levels make it difficult to use the E472/2 mice Figure 1. Schematic Diagram of the E47 Targeting Construct and
Analysis of E12 and E47 Expression in the Mutant Miceto analyze and interpret the role of E47 in B lineage
(A) Partial genomic organization of the E2A locus indicating thedevelopment. To generate mice that express E12 at lev-
E12- and E47-specific exons. Closed boxes indicate exons and theels comparablewith that of wild-type mice, we produced
shaded area indicates the neo gene. The PMC1-Neo-poly(A) markertransgenic mice expressing E12 under the control of the
is in the E47-specific exon in the same transcriptional orientation
pim-1 promoter and the immunoglobulin heavy chain as the E2A gene. The expected fragment sizes after digestion with
gene enhancer. This vector was previously shown to the indicated enzyme and hybridization with the indicated probe
allow ubiquitous expression of a bmi transgene as early are shown below. Restriction sites used for cloning are as follows:
as day 12.5 postcoitum in wild-type embryos (Alkema RV, Eco RV; S, SacI; R, EcoRI; Xb, Xba I; B, Bam HI.
(B) ES cell DNA was digested with EcoRI and assayed by Southernet al., 1995). Furthermore, the vector allowed high level
blotting for hybridization to probe A (left). Blots show targeted andexpression of the bmi transgene in bone marrow and
nontargeted alleles. The sizes of the fragments are indicated byspleen (Alkema et al., 1995). Founders expressing the
arrows. Tail DNA was used for genotyping (right). Genotypes are
E12 transgene were crossed into the E2A2/2 and E472/2 as follows: plus/plus, wild-type; plus/minus, heterozygous; minus/
backgrounds. However, because of the high rate of minus, homozygous mutant.
postnatal lethality in the E2A null mutant mice, we fo- (C) Western blot analysis of E12 and E47 protein levels in thymus
nuclear extract from wild-type and E472/2; E12T mice using mono-cused our studies on E472/2 mice expressing the E12
clonal antibodies specific for either E12 (382.6) or E47 (32.1).transgene. Western blot analysis of thymus nuclear ex-
tract was performed using antibodies specific for E12
E12 to be expressed at levels similar to that of wild-typeand E47. While E47 protein is undetectable in the E472/2
mice (data not shown). In the experiments describedmice expressing the E12 transgene, E12 was expressed
below, we will refer to mice carrying the targeted muta-at slightly higher than wild-type levels in the E472/2
tion in the E47 exon and expressing the E12 transgenebackground (Figure 1C). We also assayed for the pres-
ence of E12 transcripts in the bone marrow and found as E472/2; E12T mice.
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Figure 2. Flow Cytometric Analysis of Splen-
ocytes and Bone Marrow Cells Derived from
Wild-Type and Null Mutant Mice
(A) Two-color flow cytometric analysis of
splenocytes from a 5-week-old E472/2; E12T
mouse and a wild-type littermate. The B cell
compartment was analyzed by staining with
anti-B220-FITC and anti-IgM-PE. The per-
centage of IgM1 cells is indicated.
(B) Two-color flow cytometric analysis of
bone marrow cells from a 5-week-old E472/2;
E12T mouse and a wild-type littermate. The
B cell compartment was analyzed by staining
with anti-B220-FITC and anti-IgM-PE. The
percentages of B2201IgM1 and B2201IgM2
cells are indicated.
E47 Null Mutant Mice Lack Mature but lack BP1 and HSA expression. In addition, a percent-
age of fraction A cells show DJH rearrangements. WeB Lymphocytes
note, however, that not all B2201CD431 fraction A cellsWe and others had previously shown that E2A null mu-
belong to the B lineage. Within fraction A is a subpopula-tant mice are blocked at a stage in which very few
tion of cells that coexpresses B220, CD43, and NK1.1B2201CD431 cells are formed (Bain et al., 1994; Zhuang
and has been identified as a precursor of natural killeret al., 1994). To determine whether E47 is required for
cells (Rolink et al., 1996). These cells, which lack re-the maturation of B lymphocytes, we analyzed lymphoid
arrangements, also lack expression of B lineage–populations in the bone marrow and spleens of E2A2/2,
associated transcripts such as VpreB and B29 (RolinkE472/2, and E472/2; E12T mutant mice. Splenocytes
et al., 1996). Fraction B cells express B220, CD43, andfrom wild-type mice and six null mutant mice were ana-
HSA, but lack BP-1. Most fraction B cells have under-lyzed by flow cytometry for the presence of surface IgM1
gone DJ rearrangements and are initiating VDJ re-cells. B cells expressing B220 and IgM are absent in
arrangement. Fraction C cells express all four cell sur-E2A2/2, E472/2, and E472/2; E12T mice (Figure 2A). Six
face markers and show immunoglobulin DJ and VDJmutant mice expressing the E12 transgene were ana-
rearrangements. Finally, B2201CD432 pre-B cells ex-lyzed with essentially identical results. To determine
press cytoplasmic m and are in the process of rearrang-whether mature B lymphocytes are present in bone mar-
ing their immunoglobulin light chain genes. Flow cyto-row of E47 null mutant mice, cells derived from the
metric analysis shows that the bone marrow from E2A2/2bone marrow were analyzed by flow cytometry for the
and E472/2 mice contains a very small percentage ofpresence of surface IgM1 lymphocytes. B2201IgM1
B2201CD431 cells, but lacks B2201CD432 cells (Figurecells are undetectable in bone marrow from E2A2/2,
3, upper panels). In comparison, E472/2; E12T mutant
E472/2, and E472/2; E12T mice (Figure 2B). However,
mice show significantly increased numbers of B2201
we note that bone marrow from E472/2; E12T mice con-
CD431 cells (Figure3, upper panels). B2201CD432 pre-B
tains a higher portion of cells that are B2201CD431 as lymphocytes, however, are clearly absent in the E472/2;
compared with E2A null mutant mice (Figure 2B). These E12T mutant mice (Figure 3). We further examined the
data indicate that E47 is required for proper B cell devel- B2201CD431 populations for HSA and BP-1 expression
opment and, furthermore, suggest that E12 allows the (Figure 3, lower panels). The majority of the pro-B cells
maturation of increased numbers of B2201 cells as com- in the E2A2/2 and E472/2 mice are HSA2, indicating an
pared with mice lacking both E2A gene products. arrest in fraction A (Figure 3, lower panels). However,
To determine more precisely where B cell develop- E472/2; E12T mice have theability to generateB lympho-
ment is blocked in the mutant mice, we analyzed bone cytes that express HSA and a small number of B cells
marrow for the expression of four B lineage–associated that expressboth HSA and BP-1 (Figure 3, lower panels).
markers. The early stages of B cell development can be Taken together, these data indicate that in the absence
characterized by the differential expression of the CD43, of E47, B lymphocyte development is perturbed at the
BP-1, and heat-stable antigen (HSA) cell surface mole- pro-B cell stage. The data also suggest that E12 per-
cules (Hardy et al., 1991; Ehlich et al., 1993) and by the forms a function at an early stage of B cell development
status of gene rearrangements within the immunoglobu- as E472/2; E12T mutant mice generate a small number
lin loci (Alt et al., 1984, 1992; Yancopoulos and Alt, 1985). of pro-B lymphocytes expressing HSA and BP-1 as com-
pared with E2A-deficient mice.B lymphocytes of fraction A express B220 and CD43,
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Figure 3. Flow Cytometric Analysis of Bone
Marrow Cells Derived from Wild-Type and
Mutant Mice
Four-color flow cytometric analysis of bone
marrow cells from a 2-month-old wild-type,
E472/2, E472/2; E12T, and E2A2/2 mouse. The
B cell populations were analyzed using anti-
bodies to B220, CD43, BP-1, and HSA. Inset
boxes in the upper panels indicate B2201
CD431 populations that were gated and ana-
lyzed for expression of HSA and BP-1 (lower
panels). Boxes in the lower panels indicate
the HSA1 populations.
Analysis of Immunoglobulin Gene Rearrangements of DJH rearrangements, which we estimate by Phospor-
Imager analysis to be 7%–10% of wild-type levels (Fig-in Mice Lacking E47
To examine the B lymphocyte deficiency in the null mu- ure 4B, lane 3). Similarly, while VDJ recombination is
absent in E2A2/2 and E472/2 mice, E472/2; E12T micetant mice at the molecular level, DNA from bone marrow
of wild-type, E2A2/2, E472/2, and E472/2; E12T mutant show detectable levels of VDJ recombination (5%–7%)
(Figure 4C, lanes 1 and 3; data not shown). These data,mice were analyzed for the presence of immunoglobulin
gene rearrangements by polymerase chain reaction consistent with the flow cytometric data, indicate the
presence of a population of committed pro-B cells in(PCR) analysis using degenerate VH and DH primers
(Feeney, 1991, 1992; Schlissel et al., 1991a, 1991b; Fig- the E472/2; E12T mutant mice. Thus, the absence of
both E12 and E47 may prevent B lymphocytes fromure 4A). As described previously, IgHDJ rearrangements
are undetectable in bone marrow from E2A2/2 mice (Fig- progressing to a state in which they are committed to
the B cell lineage and have the ability to undergo IgHure 4B, lane 1) (Bain et al., 1994; Zhuang et al., 1994;
Sun, 1994). The bone marrow from the E472/2 mice is gene rearrangements. The presence of E12 would then
allow for commitment to the B cell lineage as evidencedidentical to that of the E2A-deficient mice in that it lacks
immunoglobulin gene rearrangements (data not shown). by the presence of both DJ and VDJ joints in the E472/2;
E12T mice.In contrast, E472/2; E12T mice show significant levels
Analysis of Developmentally Restricted
Transcripts in E2A and E47 Null
Mutant Mice
We previously demonstrated that CD19, mb-1, RAG-2,
and l5 transcripts are lacking in fetal liver and bone
marrow derived from E2A2/2 mice (Bain et al., 1994). To
determine whether the pro-B lymphocytes present in
the E472/2; E12T mice express these markers, we as-
sayed for their presence by reverse transcription–PCR
(RT–PCR). While E2A2/2 mice lack transcripts for CD19,
mb-1, and l5, these transcripts are clearly present in
E472/2; E12T mice (Figure 5A). Consistent with the flow
cytometric data, these data demonstrate that E472/2;
E12T mice have the ability to generate cells that are
committed to the B lineage.
The E2A2/2 phenotype strongly resembles that of
mice deficient for interleukin-7 (IL-7) or the IL-7 receptor
a (IL-7Ra) subunit (Peschon et al., 1994; von Freeden-
Jeffry et al., 1995). To determine whether the B cell
deficiency in E2A2/2 and E472/2; E12T mice is due to an
inability to express IL-7Ra, we examined the lymphoid
populations in these mice for the presence of IL-7Ra
transcripts. Reverse transcription analysis of bone mar-
row RNA showed that IL-7Ra transcripts are clearly
present in both E2A and E472/2; E12T mice, albeit at
Figure 4. Analysis of IgH DJ and VDJ Rearrangements in Wild-Type
reduced levels compared with wild-type mice (Figureand Mutant Mice
5A). Thus, the B cell deficiency in these null mutant mice
Shown in (A) is a schematic diagram of the V, D, and J regions of
is not due to an inability to express IL-7Ra.the IgH heavy chain gene locus. DNA from wild-type (1/1), E2A-
Recently, several transcription factors including Pax-5deficient (E2A2/2), and E472/2; E12T mice was examined for the
presence of DJ (B) and VDJ (C) rearrangements. and EBF have been shown to be important regulators
E12 and E47 in B Lineage Development
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Figure 5. Analysis of Hematopoietic Re-
stricted Transcripts in Wild-Type and Mutant
Mice
(A and B) RNA from bone marrow of E2A2/2,
E472/2; E12T, and wild-type mice was exam-
ined for the presence of various B lineage–
associated transcripts by RT–PCR.
(C) Positive and negative control RT–PCR re-
actions using b-actin and E47 primers.
of early B cell differentiation (Lin and Grosschedl, 1995; are absent from the spleens of E2A2/2 and E472/2 mice,
a population of surface IgM1 cells is clearly present inUrbanek et al.,1994). To gain more insight into the hierar-
the spleens of E2A2/2; E47T and E472/2; E47T mice,chy of transcription factors promoting early B cell devel-
thus indicating that ectopic expression of E47 allowsopment, we analyzed RNA isolated from wild-type and
the generation of mature B cells (Figure 6A). We note,null mutant mice for the presence of EBF and Pax-5
however, that the number of mature B cells generatedtranscripts. RT–PCR analysis of bone marrow shows
is significantly decreased in the null mutant mice ex-that Pax-5 mRNA is absent in E2A-deficient mice, but
pressing the E47 transgene (4.7% versus 50% and 7%clearly detectable in E472/2; E12T mice, albeit at lower
versus 53%). To examine the role of E47 in early B celllevels (Figure 5B). EBF transcripts can be detected at
development, we analyzed bone marrow cells by flowlow levels in the E2A-deficient mice, consistent with the
cytometry. Expression of the E47 transgene in both theexpression of EBF in B2201CD431HSA2 cells (Lin and
E2A2/2 and theE472/2 background results in the appear-Grosschedl, 1995; Figure 5B). The level of expression
ance of surface B2201IgM1 cells, although at an approx-of EBF is, however, increased in the E472/2; E12T mice
imately 15-fold lower frequency as compared with wild-(Figure 5B). Although we cannot exclude the possibility
type mice (Figure 6B). Interestingly, the population ofthat the lack of E47 affects the expression of these
B2201IgM2 lymphocytes is decreased only 3- to 7-foldgenes, the reduction of Pax-5 and EBF transcripts in
in null mutant mice expressing the E47 transgene (Figurethe E472/2; E12T mice is likely due to a significantly
6B). To characterize the early B cell defect further, wesmaller number of pro-B cells present in these mice.
analyzed bone marrow for the expression of B220 andThe presence of both EBF and Pax-5 transcripts in bone
CD43. Null mutant mice expressing the E47 transgenemarrow of mice expressing E12 does, however, provide
show a distinct population of B2201CD432 cells, albeitfurther evidence that these mice contain cells that are
at reduced percentages (4.7% versus 22.5% and 4.1%committed to the B lineage.
versus 42%) (Figure 6C). In contrast, mutant mice ex-
pressing the E47 transgene have close to normal num-Ectopic Expression of E47 in E2A Null Mutant
bers of B2201CD431 pro-B cells (4% and 2%) (FigureMice Allows Inefficient Maturation
6C). These data indicate that ectopic expression of E47
of Mature B Cells in an E2A-deficient background is sufficient to generate
Collectively, the results reported above indicate that small numbers of mature B cells. Furthermore, the data
E47 is required for the development of IgM1B2201 B suggest a deficiency in the pro-B to pre-B transition in
lymphocytes. To determine whether E47 is sufficient for cells expressing only E47.
the generation of mature B lymphocytes, we crossed
mice ectopically expressing E47 into the E2A2/2 and E12 Enhances the Ability of E47 to Promote
E472/2 mice. Transgenic mice expressing E47 from the B Lymphocyte Development
pim-1 promoter and IgH enhancer were generated as As shown above, E47 is capable of promoting B lympho-
described above. One out of five founders expressed cyte development in the absence of E12. However, al-
E47 at approximately wild-type levels (data not shown). though the levels of E47 are similar to that in wild-type
The founder was crossed into the E2A and E47 null mice, the ectopic expression of E47 leads to an incom-
mutant backgrounds, and mutant mice containing the plete rescue (Figure 6A). To determine whether ectopic
transgene were analyzed for the ability to undergo B cell coexpression of E12 enhances the ability of E47 to res-
maturation. Splenocytes from wild-type and null mutant cue the B cell deficiency, we crossed both transgenes
mice expressing the E47 transgene (referred to as into a null mutant background. Mice were analyzed for
E2A2/2; E47T and E472/2; E47T) were analyzed by two- the presence of the transgenes and the null mutant al-
leles by PCR, and littermates containing one or bothcolor flow cytometry. Whereas B2201IgM1 lymphocytes
Immunity
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Figure 6. Ectopic Expression of E47 Allows
B Cell Maturation in an E2A-Deficient Back-
ground
(A) Two-color flow cytometric analysis of
splenocytes from 1-month-old E2A and E47
null mutant mice and null mutants expressing
the E47 transgene. In each case the mice
were littermates. Splenocytes were analyzed
by staining with anti-B220-FITC andanti-IgM-
PE. The percentage of IgM1 cells is indicated.
(B) Two-color flow cytometry analysis of bone
marrow isolated from wild-type and mutant
mice as indicated. The bone marrow cells
were analyzed by staining with anti-B220-
FITC and anti-IgM-PE.
(C) Two-color flow cytometric analysis of bone
marrow cells derived from wild-type and mu-
tant mice as indicated. The cells were ana-
lyzed for the presence of early B cell popula-
tions by staining with B220-FITC and CD43-PE.
transgenes were analyzed by flow cytometry (Figure 7A). 15). Taken together, these data indicate that ectopic
expression of E12 enhances the ability of E47 to recon-Both the E472/2 and E472/2; E12T mice lack B2201IgM1
B lymphocytes in the spleen, consistent with the previ- stitute the B lineage deficiency in the E47 null mutant
mice.ous data (Figures 2A and 7A). Ectopic expression of
E47, as described above, leads to a partial rescue of
the B cell deficiency (Figures 6A and 7A). Interestingly,
Discussionwhen both E12 and E47 were ectopically expressed in
the E472/2 background, a significantly higher percent-
E12 and E47 were originally identified as two proteinsage of surface IgM1 B lymphocytes could be detected
with the ability to bind to E2-box sites present in the(21% versus 5%) (Figure 7A). In the bone marrow, E12/
immunoglobulin heavy and light chain gene enhancersE47 synergy can also be detected, as a significantly
(Murre etal., 1989a; Henthorn et al., 1990). In subsequenthigher number of B2201IgM1 lymphocytes are present
experiments, it was shown that B cell nuclear extractsin the null mutant background containing both trans-
contain a specific binding activity consisting of an E2Agenes compared with E12 or E47 alone (Figure 7B).
homodimer (Murre et al., 1991; Shen and Kadesch,These data indicate that E12 has the ability to enhance
1995). E2A binding activity is inducedduring B cell differ-the function of E47 in promoting B lineage development.
entiation prior to immunoglobulin gene rearrangementsTo examine E12 and E47 transcript levels in the vari-
and immunoglobulin gene expression (Xin et al., 1994).ous littermates containing the transgene(s), we assayed
Taken together, these data suggested a key role forfor the presence of E12 and E47 mRNA levels (Figure
E47 in various aspects of B lymphocyte development.7C). Both the E12 and E47 transgenes were derived from
Further experiments using E2A-deficient mice con-human cDNAs, thus allowing us to assess RNA levels
firmed a crucial role for E2A proteins in B cell develop-by RNase protection using a human cDNA as a probe.
ment. B2201 cells in E2A mutant mice were shown toThe E12 probe protects a fragment of predicted size in
be blocked at a stage prior to the initiation of immuno-null mutant mice expressing the E12 transgene (Figure
globulin gene rearrangements and the expression of a7C, lanes 6 and 8; arrow 2). Similarly, the human E47
number of B lineage–associated transcripts (Bain et al.,probe is protected from RNase digestion in mice ex-
1994; Zhuang et al., 1994; Sun, 1994). In the studiespressing the E47 transgene (Figure 7C, lanes 14, 15, and
described here, we have examined the individual roles16; arrow 6). Similarities between the mouse and human
of E12 and E47. Our data indicate that both E12 andsequences result in the production of a number of
E47 are required for proper B lymphocyte development,smaller protected fragments, many of which are present
but exhibit distinct functional properties. E12 allows thein all E472/2 mice using the E47 probe (Figure 7C, lanes
development of cells that are committed to the B lin-13, 14, 15, and 17; arrows 9, 10, and 11). These fragments
eage, as evidenced by the presence of both VDJ jointsresult from hybridization to aberrant transcripts pro-
and a number of B cell–restricted transcripts in E12-duced from the targeted locus (Figure 7C; see figure
expressing mice. E47 is sufficient to generate mature Blegends). Most importantly, the RNase protection data
cells in theabsence of E12, albeit insignificantly reducedshow that E47 mRNA levels are comparable in both the
single and double transgenics (Figure 7C, lanes 14 and numbers. These observations indicate that both E12 and
E12 and E47 in B Lineage Development
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Figure 7. E12 and E47 Act Synergistically to
Drive B Lymphocyte Differentiation
Splenocytes from transgenic mice express-
ing E12 or E47 (or both) in the E472/2 back-
ground were analyzed by flow cytometry for
the presence of B2201IgM1 lymphocytes. All
mice, except for the E472/2; E12T, were lit-
termates. The percentage of IgM1 cells is in-
dicated.
(A) Two-color flow cytometric analysis of
splenocytes derived from wild-type and mu-
tant mice as indicated. Splenocytes were an-
alyzed for the presence of B220 and IgM.
(B) Two-color flow cytometric analysis of
bone marrow cells derived from wild-type and
mutant mice as indicated. Bone marrow cells
were analyzed for the presence of B220 and
IgM.
(C) E12 and E47 transcript expression in wild-
type and null mutant mice. RNase protection
on bone marrow RNA using a human E12
probe (left panel) and a human E47 probe
(right panel) is shown. Lanes 16 and 17 are
from a different gel. Given the regions of iden-
tity between E12 and E47 and between the
mouse and human sequences, a number of
different fragments are protected (numbered
1–11). The fragments, indicated by numbered
arrows, are as follows: 1, E12 full-length
probe, nonhybridized (lane 1); 2, human E12 transcript expressed from the E12 transgene (lanes 6 and 8); 3, human E47 transcript expressed
from the E47 transgene and hybridizing to the 59 end of the E12 probe (lanes 7 and 8); 4, endogenous wild-type mouse E12 transcript
hybridizing to the human E12 probe (lane 3); 5, E47 full-length probe, nonhybridized (lane 9); 6, human E47 transcript expressed from the E47
transgene (lanes 14–16); 7 and 8, endogenous wild-type mouse E12 and E47 transcripts hybridizing to the E47 probe (lane 11); 9–11, aberrant
mouse transcripts from the E47 targeted locus (lanes 13–15 and 17).
E47 allow commitment to the B lineage. While E12 alone (Murre et al., 1991; Bain et al., 1993; Shen and Kadesch,
is unable to rescue B lineage development, it enhances 1995). Furthermore, E47 has the ability to bind the kE1
the ability of E47 to promote B cell differentiation. and kE2 sites present in the immunoglobulin light chain
gene enhancer (Murre et al., 1991). E2-box sites are also
present in the immunoglobulin 39 enhancers (PongubalaThe Role of E47 in B Lymphocyte Development
and Atchison, 1991). Thus, a critical role for E47 in con-The data shown here indicate that E47 is essential for
trolling Blymphocyte development was expected.Previ-mature B cells to develop and to emigrate to and popu-
ous studies have suggested that E47 might play a rolelate the peripheral organs. How is E47 involved in B
in controlling immunoglobulin gene rearrangementscell development? Previous biochemical studies have
(Schlissel et al., 1991a). Overexpression of E47 in a pre-Tindicated that E47 binds to the mE2, mE5, and mE4 sites
of the immunoglobulin heavy chain gene enhancer cell line leads to an increase in the frequency of IgH DJ
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rearrangements (Schlissel et al., 1991a) and suggests E12 contain B cell–restricted transcripts, including
that E47 may regulate the accessibility of V, D, and J mb-1, l5, and CD19, whereas E2A-deficient mice lack
segments to the recombination machinery. The experi- these transcripts. Taken together, these data suggest
ments shown here do not provide evidence for a role that the B2201CD431 population present in the E2A2/2
of E47 in controlling rearrangement. The reduction in mice represent cells that are not committed to the B
IgH DJ and VDJ rearrangements in mice lacking E47, lineage and that expression of E12 then allows commit-
but expressing E12, can beexplained by the significantly ment to the B lineage.
smaller population of B2201 cells in these mice as com-
pared with their wild-type littermates.
Reconstitution of the B Cell LineageIn a wild-type mouse, a population of thymocytes will
in E2A-Deficient Miceshow IgH DJ rearrangements. We have tested whether
We show here that the ectopic expression of E47 andimmunoglobulin DJ rearrangements are present in thy-
E12 allows a reconstitution of the B lineage compart-mocyte DNA from both E2A and E47 null mutant mice.
ment, but the rescue is partial. We would like to considerOur data show that IgH DJ rearrangements in the E2A
several explanations for the incomplete reconstitutionand E47 null mutant mice are comparable with that of
of the B cell compartment upon coexpression of E12wild-type thymocytes (G. B. and C. M., unpublished
and E47. First, the timing and expression levels of thedata). These data suggest that E2A gene products are
transgenes may not be optimal at key points during Bnot required for immunoglobulin DJ rearrangements in
cell maturation. Second, both transgenes are derivedthymocytes. However, it is conceivable that closely re-
from human cDNAs, and it is conceivable that minorlated class IHLH proteins have theability tocompensate
amino acid differences between human and murine E2Afor the loss of E2A proteins in thymocytes, thus allowing
proteins affect E2A function. Third, whereas E12 andDJ recombination to occur. Consistent with this notion
E47 can exist as two alternatively spliced forms, whichis our observation that thymocytes from E2A null mutant
differ by the presence or absence of an N-terminal trans-mice contain E2-box-binding proteins that consist of
activation domain, the transgenes express only one ofHEB homodimers (G. B. and C. M., unpublished data).
these forms. It is conceivable that expression of bothIf the critical role for E47 is to regulate substrate ac-
forms is required to obtain full rescue of the E2A defi-cessibility of the immunoglobulin loci, the introduction
ciency. Although the reconstitution is incomplete, theof a rearranged immunoglobulin heavy and light chain
demonstration that ectopic expression of the E2A pro-gene should rescue the B cell deficiency in E47 null
teins can reconstitute the B cell lineage in an E2A-defi-mutant mice, as has been described for the reconstitu-
cient background will enable a functional analysis of thetion of the B cell lineage in RAG null mutant mice (Spano-
conserved domains (Aronheim et al., 1993; Massari etpoulou et al., 1994; Young et al., 1994). We have gener-
ated such mice and found that, unlike the RAG null al., 1996; Quong et al., 1993).
mutant mice, the presence of an immunoglobulin heavy
and light chain gene does not reconstitute the B cell IL-7 and E2A Deficiency
lineage inmice lacking E47 (G. B. and C. M., unpublished
Interestingly, the phenotype in mice lacking E47 is simi-
data). We note that these data do not exclude the possi-
lar to that observed in mice treated with a neutralizing
bility that E47 is required for immunoglobulin gene re-
antibody directed against IL-7/IL-7R and in IL-7Ra nullarrangements, but rather indicates that E47 has, as well,
mutant mice (Sudo et al., 1989; Peschon et al., 1994;other critical functions during B lineage development.
Grabstein et al., 1995; von Freeden-Jeffry et al., 1995).
B cell differentiation in each of these mice is perturbedThe Role of E12 in B Lymphocyte Development
at a stage prior to the expression of BP-1. Furthermore,In contrast with E47, the biochemical nature and role of
IL-7 was shown to be required for the expression of aE12 in the B cell lineage has been less well documented.
number of B lineage–restricted genes, including l5,E12 binds with weak affinity to the E2-box site owing
mb-1, and RAG-1, but not B29 (Kee and Paige, 1996).to an inhibitory domain located immediately N-terminal
The pattern of expression of these genes is strikinglyof the basic region (Sun and Baltimore, 1991). Although
similar to that of mice lacking the E2A gene productsE12 binding activity cannot be detected, E12 protein
(Bain et al., 1994; unpublished data). The data shownlevels in B lymphocytes are comparable with that of E47
above demonstrate that IL-7Ra transcripts are clearly(unpublished data). Whereas E12 and E47 clearly have
detectable in both the E2A and E47 null mutant mice.distinct DNA binding properties, both activate E-box
Thus, it is unlikely that E2A proteins are required for thereporters to similar degrees in a number of fibroblast
expression of the IL-7Ra gene. Rather, it is conceivableand T cell lines (unpublished data).
that E2A proteins function downstream of IL-7Ra andWhat, then, is the function of E12 in B lymphocyte
that E2A proteins are activated by IL-7 to promote Bdevelopment? The presence of E12 increases the num-
lineage commitment and development. For example,ber of B2201 cells as compared with mice lacking both
IL-7 may down-regulate members of the Id gene family,E2A gene products. In the presence of E12, B lympho-
allowing E12 and E47 to bind to their target sites andcytes have the ability to differentiate into HSA1BP-12
activate gene expression. An alternative scenario is thatand HSA1BP-11 pro-B cells, albeit at significantly re-
E12 and E47 are activated by a different pathway, induced numbers compared with wild-type mice. Further-
parallel to IL-7, to induce B lineage commitment andmore, lymphocytes in mice lacking E47 but expressing
differentiation.E12 have the ability to undergo IgH DJ and VDJ recombi-
In summary, the above studies show that both E12nation, whereas E2A2/2 mice lack DJ and VDJ re-
arrangements. Our data also show that mice expressing and E47 play critical yet distinct roles in B lymphocyte
E12 and E47 in B Lineage Development
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scatter. Four-color analysis was performed as described previouslydevelopment. Both E12 and E47 allow commitment to
(Hardy et al., 1991).the B cell lineage and act in concert to promote B lym-
phocyte differentiation.
PCR Assays
DNA was prepared from bone marrow of 6-week-old control (1/1)
Experimental Procedures and mutant (2/2) mice as described previously (Bain et al., 1994).
Immunoglobulin DH to JH rearrangement was analyzed by PCR using
Generation of Null Mutant and Transgenic Mice a degenerate DHL primer as previously indicated (Feeney, 1991,
The 8.5 kb l clone used for the E12 targeting construct contained 1992; Schlissel et al., 1991b). VH to DH rearrangement was analyzed
the E47 exon and so was also used for the E47 targeting construct using the degenerate variable region VH7183 primer with the JH3
(Bain et al., 1994). An approximately 1.5 kb XbaI–HindIII fragment primer (Feeney, 1992). Approximately 200 ng of genomic DNA was
containing the E47 exon was subcloned into pBSK and digested used for the PCR assay, which was done in 25 ml reaction volumes
partially with PstI. A 1 kb pMC1-Neo fragment (te Riele et al., 1992; using 2.5 ml of 103 PCR buffer (Perkin Elmer), 0.25 mM of each
Thomas and Capecchi, 1987) was inserted into the PstI site within dNTP, 1.5 mM MgCl2, 25 ng of each primer, and 1 U of Taq polymer-
the E47 exon in the same transcriptional orientation as the E2A ase (Perkin Elmer). The PCR products were fractionated on agarose
gene. The XbaI–HindIII fragment containing the neo gene was then gels and analyzed by Southern blotting using the DJ3 product as a
cloned back into the original 8.5 kb fragment. The targeting con- probe. RNA was isolated from the bone marrow using TriZOL re-
struct was electroporated as a BamHI fragment. Electroporation, agent (GIBCO BRL). Randomly primed cDNA was synthesized from
growth, and selection of the ES cells was performed as described 3 mg of total RNA as described previously (Bain et al., 1994). PCR
previously (Bain et al., 1994). Colonies resistant to G418 were conditions and primers used are as described previously (Bain et
screened for homologous recombination by digestion of ES cell al., 1994). The EBF and actin primers used are as follows: EBF
DNA with EcoRI and Southern blotting using a 39 external probe forward, 59-CTCACTTTGAGAAGCAGCCGCCTTCT-39; EBF reverse,
(Figure 1A). 59-CATGTCACGTGGGTTTCCTGCATTCT-39; actin forward, 59-TGG
For construction of the transgene vectors, an approximately 2.7 AATCCTG TGGCATCCATGAAAC-39; actin reverse, 59-TAAAACGCA
kb EcoRI–XbaI fragment containing the human E12 cDNA and a 2.2 GCTCAGTAACAGTCCG-39. PCR products were run on a 2.2% nu-
kb XbaI fragment containing the human E47 cDNA were blunted sieve agarose gel, transferred to nytran, and hybridized with gene-
and cloned into the HpaI site of the Em-Pim-1 vector described specific probes.
previously (Alkema et al., 1995). Potential founders were bred to
FVB mice (Jackson Laboratories), and the offspring were screened
RNase Protectionfor the presence of the transgene by digestion of tail DNA with KpnI
For RNase protection, a 291 bp SmaI–EcoRI fragment containing aand Southern blotting using probes from the human E12 bHLH or
portion of the human E12 cDNA from the middle of the HLH regionhuman E47 bHLH region. Founders were screened for the expres-
to the end of the cDNA was subcloned into pBSK. The plasmid wassion of the transgene by Western blotting on thymus nuclear extract
linearized with SmaI and transcribed with T7 RNA polymerase towith a monoclonal antibody specific for the human E2A proteins.
generate the probe. The E47S plasmid described previously (Murre
et al., 1989b) contains a fragment of the human E47 cDNA encoding
Western Blotting most of the bHLH region and a small region upstream of the bHLH.
Western blotting was performed as follows: 30 mg of thymus nuclear pE47S was linearized with HindIII and transcribed with T7 RNA
extract was run on an 8% SDS–polyacrylamide gel. After running, polymerase to generate the probe. Bone marrow RNA was prepared
the gel was transferred to nitrocellulose and blocked overnight at using TriZOL reagent (GIBCO BRL) and 15 mg was annealed to 1 3
48C with blocking buffer (50 mM Tris, 150 mM NaCl [pH 7.5], 5% 106 cpm of probe overnight at 558C. Samples were digested with
powdered milk). Blots were incubated for 2 hr at room temperature RNase, precipitated, and run on a 5% acrylamide, 8 M urea gel at
in blocking buffer containing the following antibodies (all obtained 50 W for 30–40 min.
from Pharmingen, San Diego, CA): 1:500 dilution of the human E2A-
specific monoclonal antibody 271.1 (transgene expression in the
Acknowledgmentswild-type background); 1:500 dilution of 382.6 (specific for mouse
and human E12); 1:250 dilution of 32.1 (specific for mouse and
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